E
XTL Biopharmaceuticals Ltd. XTLB
$0.8038 -$0.0557-6.48%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022 06/30/2022 03/31/2022 12/31/2021
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 219.00K 201.00K 187.00K 243.00K 280.00K
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 225.00K 204.00K 202.00K 249.00K 286.00K
Operating Income -225.00K -204.00K -202.00K -249.00K -286.00K
Income Before Tax -748.00K -821.00K -285.00K 506.00K 2.10M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -748.00K -821.00K -285.00K 506.00K 2.10M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -748.00K -821.00K -285.00K 506.00K 2.10M
EBIT -225.00K -204.00K -202.00K -249.00K -286.00K
EBITDA -224.80K -203.80K -201.80K -248.80K -285.80K
EPS Basic 0.00 0.00 0.00 0.00 0.00
Normalized Basic EPS 0.00 -- 0.00 -- 0.00
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Normalized Diluted EPS 0.00 -- 0.00 -- 0.00
Average Basic Shares Outstanding 544.91M 544.91M 544.91M 544.91M 544.62M
Average Diluted Shares Outstanding 544.91M 544.91M 544.91M 544.91M 878.84M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings